A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited ...

Gilead Sciences ( ($GILD) ) has risen by 7.31%. Read on to learn why. Gilead Sciences has seen a notable increase in its ...

That being said, we’re here with a list of the 10 most profitable new stocks to buy now. We sifted through the Finviz stock screener to compile a list of the top companies that went public in the last ...

These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

It will be piloted in Cambridge on the PemOla trial, a precision medicine study exploring a combination immunotherapy, using ...

The move has triggered a $75m milestone payment to Vir as part of its 2024 exclusive global licence agreement with Sanofi.

The trial will include patients with non-small cell lung, colorectal, head and neck, and cutaneous cancers with EGFR amplification.

Revised Phase 2 Strategy Targets Event-Free Survival in Primary Head and Neck Cancer through Checkpoint Inhibitor Combination ...

The growing incidence of HPV16-positive cancers represents a significant challenge in oncology despite recent therapeutic advances. In this exclusive interview, Frank Bedu-Addo, President and CEO of ...

During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a ...

USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...